100 related articles for article (PubMed ID: 35443541)
41. Blind spot in lung cancer lymph node metastasis: Cross-lobe peripheral lymph node metastasis in early stage patients.
Li N; Tan F; Li J; Shao K; Zhao J; Mu J; Gao S; He J
Thorac Cancer; 2018 Apr; 9(4):480-485. PubMed ID: 29517861
[TBL] [Abstract][Full Text] [Related]
42. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients.
Gejman R; González S; Muñoz-Medel M; Nervi B; Sánchez C; Ibáñez C; Peña J; Madrid J; Briones J; Pérez P; Garrido M; Galindo H
Asian Pac J Cancer Prev; 2019 Jan; 20(1):1-4. PubMed ID: 30677862
[TBL] [Abstract][Full Text] [Related]
44. [Trend analysis and clinicopathological characteristics of 198 young patients with advanced lung adenocarcinoma].
Li YF; Wang Y; Li JL; Hao XZ; Hu XS; Wang HY
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):750-755. PubMed ID: 27784458
[No Abstract] [Full Text] [Related]
45. [Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study].
;
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):882-890. PubMed ID: 34344071
[No Abstract] [Full Text] [Related]
46. Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.
Nagata M; Kudoh S; Mitsuoka S; Suzumura T; Umekawa K; Tanaka H; Matsuura K; Kimura T; Yoshimura N; Hirata K
Osaka City Med J; 2013 Jun; 59(1):45-52. PubMed ID: 23909080
[TBL] [Abstract][Full Text] [Related]
47. [Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].
Cao H; Zheng J; Zhao J; Guo XJ; Zhou JY; Ding W; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):120-125. PubMed ID: 32062881
[No Abstract] [Full Text] [Related]
48. Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience.
Noronha V; Dikshit R; Raut N; Joshi A; Pramesh CS; George K; Agarwal JP; Munshi A; Prabhash K
Indian J Cancer; 2012; 49(1):74-81. PubMed ID: 22842172
[TBL] [Abstract][Full Text] [Related]
49. Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor.
Kwon BS; Cho YH; Yoon SK; Lee DH; Kim SW; Kwon DH; Lee JC; Choi CM
Thorac Cancer; 2020 Feb; 11(2):436-442. PubMed ID: 31910497
[TBL] [Abstract][Full Text] [Related]
50. Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathologic study.
Frizelle FA; Hobday KS; Batts KP; Nelson H
Dis Colon Rectum; 2001 Mar; 44(3):341-6. PubMed ID: 11289278
[TBL] [Abstract][Full Text] [Related]
51. Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.
Haruki T; Aokage K; Miyoshi T; Hishida T; Ishii G; Yoshida J; Tsuboi M; Nakamura H; Nagai K
J Thorac Oncol; 2015 Jun; 10(6):930-6. PubMed ID: 26001143
[TBL] [Abstract][Full Text] [Related]
52. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.
Folch E; Yamaguchi N; VanderLaan PA; Kocher ON; Boucher DH; Goldstein MA; Huberman MS; Kent MS; Gangadharan SP; Costa DB; Majid A
J Thorac Oncol; 2013 Nov; 8(11):1438-1444. PubMed ID: 24128714
[TBL] [Abstract][Full Text] [Related]
53.
Palacio S; Pontes L; Prado E; Arshad J; Ali R; Piha T; Bacchi CE; Mudad R; Lopes G
Oncologist; 2019 Apr; 24(4):e137-e141. PubMed ID: 30446583
[TBL] [Abstract][Full Text] [Related]
54. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
Zhao H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
[TBL] [Abstract][Full Text] [Related]
55. Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer.
Ying H; Yang XD; Sun Z; Ning X; Wang Y; Bai C; Chen S; Wang Y
Med Oncol; 2014 Oct; 31(10):220. PubMed ID: 25216867
[TBL] [Abstract][Full Text] [Related]
56. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous metastasis of lung carcinoma: a retrospective study of 12 cases.
Dhambri S; Zendah I; Ayadi-Kaddour A; Adouni O; El Mezni F
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):722-6. PubMed ID: 20735519
[TBL] [Abstract][Full Text] [Related]
58. Incidence and characteristics of Epidermal Growth Factor Receptor (EGFR) mutation in non-small-cell lung cancer (Adenocarcinoma histology): A report of 106 patients from Kolkata.
Chatterjee K; Ray A; Chattopadhyay B
Indian J Cancer; 2017; 54(1):305-307. PubMed ID: 29199710
[TBL] [Abstract][Full Text] [Related]
59. Lung cancer in central Tunisia: epidemiology and clinicopathological features.
Missaoui N; Hmissa S; Landolsi H; Korbi S; Joma W; Anjorin A; Ben Abdelkrim S; Beizig N; Mokni M
Asian Pac J Cancer Prev; 2011; 12(9):2305-9. PubMed ID: 22296375
[TBL] [Abstract][Full Text] [Related]
60. Clinical Characteristics and Molecular Profiles of Lung Cancer in Ethiopia.
Gebremariam TH; Haisch DA; Fernandes H; Huluka DK; Binegdie AB; Woldegeorgis MA; Ergetie W; Worku A; Zerihun LM; Cohen M; Massion PP; Sherman CB; Saqi A; Schluger NW
JTO Clin Res Rep; 2021 Jul; 2(7):100196. PubMed ID: 34590041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
